Summary
Investigation of GFAP in 50 medulloblastomas showed a few GFAP-positive tumour cells in 5 cases only; 17 tumours were negative, and 28 showed a “pseudopositivity”, i.e. GFAP-bearing cells were identified as reactive or degenerating astrocytes, intermingled with tumour elements. A high GFAP content was seen in 2 small-cell gliomas of the cerebellum, whereas 3 pineoblastomas, 2 neuroblastomas of CNS, and one medulloepithelioma were negative.
GFAP is a very good method for identificating astrocytes, but does not seem to be reliable for identifying the origin of undifferentiated tumours such as medulloblastomas. In these neoplasms glial differentiation is lacking or extremely rare, GFAP-positivity being mostly an artifact. The investigation of small tumour samples or the positivity of a single cell are inadequate data for a correct evaluation of the findings, especially taking in mind that GFAP of degenerated astrocytes can be phagocytised by cells other than glial (e.g., macrophages, epithelial and meningioma cells). The importance of carefully checking the whole structure of the tumour is stressed, GFAP positivity or negativity being not a sufficient criterion for its nosological classification.
Similar content being viewed by others
References
Bailey P, Cushing H (1925) Medulloblastoma cerebelli. A common type of midcerebellar glioma of childhood. Arch Neurol Psychiatr 14:192–224
Bignami A, Dahl D (1974) Astrocyte-specific protein and radial glia in the cerebral cortex of newborn rat. Nature 252:55–56
Bignami A, Dahl D (1977) Specificity of glial fibrillary acid protein from astroglia. J Histochem Cytochem 25:466–469
Cappricci E, Gullotta F (1981) Morphological and pathogenetic considerations of supratentorial gliomas in children. J Neurosurg Sci (Milano) 25:1–6
Cooper IS, Kernohan JW (1951) Heterotopic glial nests in the subarachnoid space. Histopathologic characteristics, mode of origin and relation to meningeal gliomas. J Neuropathol Exp Neur 10:16–29
De Armond SJ, Eng LF, Rubinstein LJ (1980) The application of glial fibrillary acidic (GFA) protein immunohistochemistry in neurooncology. Pathol Res Pract 168:374–394
Deck JHN, Eng LF, Bigbee J, Woodcok SM (1978) The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumours. Acta Neuropathol (Berlin) 42:183–190
Deck JHN, Rubinstein LJ (1980) The demonstration by immunoperoxydase of glial fibrillary acidic protein in so-called stroma neoplastic cells of some capillary haemangioblastomas: significance and possible implications. J Neuropathol exp Neurol 39:349
Delpech B, Delpech A, Vidard MN, Girard N, Tayot J, Clement JC, Creissard P (1978) Glial fibrillary acidic protein in tumours of the nervous system. Br J Cancer 37:33–40
Ghatak NR, Nochlin D (1982) Glial outgrowth along spinal nerve roots in amyotrophic lateral sclerosis. Ann Neurol 11:203–206
Gullotta F (1966) Über angeborene Mischgeschwülste des Kleinhirns. Dtsch Z Nervenheilk 189:354–374
Gullotta F (1967) Das sogenannte Medulloblastom. Springer, Berlin Heidelberg New York
Gullotta F (1979) Morphological structure and biological behaviour of medulloblastoma in relation to age. In: Paoletti P, Walker MD, Butti G, Knerich R (eds) Multidisciplinary aspects of brain tumour therapy. Elsevier/North Holland Biomedical Press, Amsterdam, New York, Oxford
Gullotta F (1981) Morphological and biological basis for the classification of brain tumours. With a comment on the WHO classification 1979. In: Krayenbühl H (ed) Advances and technical standards in neurosurgery, vol. 8. Springer, Wien New York, pp 123–165
Gullotta F, Kost HG (1980) Vitro-studies of socalled medulloblastomas. Pathologica (Genua) 72:27–34
Kersting G (1968) Tissue culture of human gliomas. Progr Nêurol Surg, vol. 2. Karger-Verlag, Basel New York
Mannoji H, Takeshita I, Fukui M, Ohta M, Kitamura K (1981) Glial fibrillary acidic protein in medulloblastoma. Acta Neuropathol (Berl) 55:63–69
Palmer JO, Kasselberg AG, Netsky MG (1981) Differentiation of medulloblastoma. Studies including immunohistochemical localization of glial fibrillary acidic protein. J Neurosurg 55:161–169
Roussy G, Lhermitte J, Oberling Ch (1930) Rapport sur la névroglie et ses réactions pathologiques. Rev. Neurol 37:878–955
Rubinstein LJ (1972) Tumours of the central nervous system. Armed Forces Institute of Pathology Washington
Spielmeyer W (1922) Histopathologie des Nervensystems. Springer, Heidelberg New York Berlin
Sternberger LA (1979) Immunocytochemistry. 2nd Ed. J Wiley a. Sons, New York, Chichester, Brisbane, Toronto
Szepan B, Gullotta F (1974) Zur diffuse Glioblastose der weichen Häute. Neurochirurgia (Stuttgart) 17:170–175
Tascos NA, Parr J, Gonatas NK (1982) Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Human Pathol 13:454–458
Van der Meulen JDM, Houthoff HJ, Ebels EJ (1978) Glial fibrillary acidic protein in human gliomas. Neuropathol Appl neurobiol 4:177–190
Velasco ME, Dahl D, Roessmann U, Gambetti PL (1980) Immunohistochemical localization of glial fibrillary acidic protein in butaan glial neoplasms. Cancer 45:484–494
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schindler, E., Gullotta, F. Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children. Vichows Archiv A Pathol Anat 398, 263–275 (1983). https://doi.org/10.1007/BF00583584
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00583584